Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3684656014 | Ruxolitinib in oral dosage form | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3684657017 | Product containing ruxolitinib in oral dosage form | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3684658010 | Product containing ruxolitinib in oral dosage form (medicinal product form) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3711814015 | Ruxolitinib-containing product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3711815019 | Product containing ruxolitinib in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ruxolitinib-containing product in oral dose form | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Ruxolitinib-containing product in oral dose form | est un(e) (attribut) | Product containing ruxolitinib (medicinal product) | true | Inferred relationship | Some | ||
| Ruxolitinib-containing product in oral dose form | a une forme pharmaceutique (attribut) | forme orale | true | Inferred relationship | Some | ||
| Ruxolitinib-containing product in oral dose form | est un(e) (attribut) | Product manufactured as oral dose form (product) | true | Inferred relationship | Some | ||
| Ruxolitinib-containing product in oral dose form | a pour principe actif (attribut) | Ruxolitinib | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ruxolitinib only product in oral dose form | est un(e) (attribut) | True | Ruxolitinib-containing product in oral dose form | Inferred relationship | Some | |
| Ruxolitinib 5 mg oral tablet | est un(e) (attribut) | False | Ruxolitinib-containing product in oral dose form | Inferred relationship | Some | |
| Ruxolitinib 10 mg oral tablet | est un(e) (attribut) | False | Ruxolitinib-containing product in oral dose form | Inferred relationship | Some | |
| Ruxolitinib 20 mg oral tablet | est un(e) (attribut) | False | Ruxolitinib-containing product in oral dose form | Inferred relationship | Some | |
| Ruxolitinib 15 mg oral tablet | est un(e) (attribut) | False | Ruxolitinib-containing product in oral dose form | Inferred relationship | Some | |
| Ruxolitinib 25 mg oral tablet | est un(e) (attribut) | False | Ruxolitinib-containing product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR